GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London S.E. Other stock markets 11:35:11 2025-12-16 am EST			5-day change	1st Jan Change
1,819.50 ^GBX	-0.76%		+2.05%	+35.13%

11:43pm	UK stocks - Factors to watch on December 17	RE
08:29pm	GSK wins US approval for twice-yearly asthma drug	RE

Transcript : GSK plc - Special Call

Published on 12/17/2024 at 08:00 am EST

S&P Capital IQ

Presenter Speech
Mick Readey (Executives)

Hello, everyone. Welcome to today's meet GSK management event, focused on the next wave of our pipeline. This is an interactive event with a presentation sent

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about GSK plc

11:43pm	UK stocks - Factors to watch on December 17	RE
08:29pm	GSK wins US approval for twice-yearly asthma drug	RE
06:17pm	GSK Exdensur (Depemokimab) approved by US FDA for treatment of severe asthma	RE
Dec. 16	The Fed's Favorite Numbers?
Dec. 16	GSK : Deutsche Bank remains Neutral	ZD
Dec. 16	GSK plc Announces the Marketing Authorisation of Exdensur ( Depemokimab) by the UK's Medicines and Healthcare Products Regulatory Agency	CI
Dec. 16	Bad News Is Good News, Again
Dec. 16	UK Stocks-Factors to watch on December 16	RE
Dec. 15	GSK Bags UK Approval for Exdensur as Asthma, Chronic Rhinosinusitis Treatment	MT
Dec. 15	GSK receives UK marketing approval for asthma treatment Exdensur	AN
Dec. 15	UK approves GSK's twice-yearly asthma drug	RE
Dec. 15	UK's MHRA approved depemokimab to treat asthma & severe chronic rhinosinusitis with nasal polyps	RE
Dec. 12	US FDA approves Innoviva's oral antibiotic for gonorrhea	RE
Dec. 12	Surprise UK GDP Contraction Keeps FTSE 100 in the Red	MT
Dec. 12	GSK plc Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025
Dec. 12	GSK Says Depemokimab Recommended for EU Approval in Asthma, Rhinosinusitis	MT
Dec. 12	GSK hails positive opinion by EU's CHMP on depemokimab and Nucala	AN
Dec. 12	European health regulator recommends approval for GSK's twice-yearly asthma drug	RE
Dec. 12	Arcus scraps late-stage cancer trial after weak survival data	RE
Dec. 12	GSK Says European Health Agency's Committee Recommends Expanded Approval for RSV Vaccine in Europe	MT
Dec. 12	GSK Gets US FDA Approval for Gepotidacin to Treat Uncomplicated Urogenital Gonorrhoea	MT
Dec. 12	GSK's Arexvy on track for wider age range approval in Europe	AN
Dec. 12	FTSE 100 to rise, UK GDP down, trade deficit spikes	AN
Dec. 12	GSK's RSV Vaccine Bags European Recommendation for Expanded Use	MT
Dec. 12	GSK gets EU regulator backing for expanded use of RSV vaccine	RE